Form 4 for RPRX Royalty Pharma plc
Accepted 2023-11-14 00:00:00 ET · period of report 2023-11-13 · accession 0001802768-23-000030 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-11-14 | 2023-11-13 | RPRX | RIGGS RORY B | Dir | C - Cnv Deriv | $0.00 | +475.6K | 490.1K | +3,278% | $0 |
| D | 2023-11-14 | 2023-11-13 | RPRX | RIGGS RORY B | Dir | C - Cnv Deriv | $0.00 | -47.6K | 300.0K | -14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Shares | 2023-11-13 | C | A | 475,590 | $0.00 | 490,099 | D | — | — | |
| 2 | Derivative | LP interests in RPI US Partners 2019, LP | 2023-11-13 | C | D | 47,559 | $0.00 | 300,000 | D | $0.00 · — to — | 47,559 Class A Ordinary Shares | (F2) Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value. |